awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36232787-3C6FA5BC-06B3-4EA2-877A-D64F9419F7F8
Q36232787-3C6FA5BC-06B3-4EA2-877A-D64F9419F7F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36232787-3C6FA5BC-06B3-4EA2-877A-D64F9419F7F8
Effects of a sodium glucose co-transporter 2 selective inhibitor, ipragliflozin, on the diurnal profile of plasma glucose in patients with type 2 diabetes: A study using continuous glucose monitoring.
P2860
Q36232787-3C6FA5BC-06B3-4EA2-877A-D64F9419F7F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36232787-3C6FA5BC-06B3-4EA2-877A-D64F9419F7F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef6d90b31f7fba73fc7fa6e21a021bf31c1bef57
P2860
Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study.